https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
39; 95% CI, 2, 81-31,38) were significantly more likely to be p16 positive. Early clinical stage (AJCC8ed) was more associated with p16 positivity both in univariate (OR, 0.14; 95% CI, 0.07-0.26, p0.001) and multivariate analysis (OR, 0.18; 95% CI, 0.06-0.49, p = 0.001). This study showed that drinkers and current smokers were less likely to be p16+. Female sex, higher education level and younger age at diagnosis were associated with a higher probability of being p16+. Additionally, there was a higher proportion of patients wit
Like
Comment
Share
